Kyeong-Ok Chang

6PUBLICATIONS
26CO-AUTHORS
Animal protection (incl. pests and pathogens)Molecular targetsProteins and peptidesMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 11, 2024
Potent small molecule inhibitors against the 3C protease of foot-and-mouth disease virus.

Yunjeong Kim, Emma Pool, Eunji Kim

|Dec 21, 2023
Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatment.

Pengfei Li, Yunjeong Kim, Chamandi S Dampalla

|Sep 18, 2023
The smallest functional antibody fragment: Ultralong CDR H3 antibody knob regions potently neutralize SARS-CoV-2.

Ruiqi Huang, Gabrielle Warner Jenkins, Yunjeong Kim

|May 02, 2023
Roles of host proteases in the entry of SARS-CoV-2.

Alexandria Zabiegala, Yunjeong Kim, Kyeong-Ok Chang

|Aug 05, 2020
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.

Athri D Rathnayake, Jian Zheng, Yunjeong Kim

|Nov 28, 2017
Trypsin-independent porcine epidemic diarrhea virus US strain with altered virus entry mechanism.

Yunjeong Kim, Changin Oh, Vinay Shivanna

Pageof 1

Frequent Collaborators

4 joint publications

Yunjeong Kim

2 joint publications

Stanley Perlman

2 joint publications

William C Groutas

1 joint publications

Athri D Rathnayake